![David Woodhouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Woodhouse
Chairman at
SURROZEN, INC.
Net worth: 61 358 $ as of 2026-05-30
Profile
David J.
Woodhouse is currently Chief Executive Officer & Director at Nuvig Therapeutics, Inc. since 2025.
He is Chairman at Surrozen, Inc. since 2023 and Director at Surrozen Operating, Inc. since 2020.
Formerly, Dr. Woodhouse was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2015.
He was Chief Executive & Financial Officer, Director at NGM Biopharmaceuticals, Inc. from 2018 to 2020.
He also worked as a Research Assistant at Amgen, Inc. Education includes undergraduate studies at the University of California, Santa Barbara, an MBA from Tuck School of Business at Dartmouth, and a doctorate from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SURROZEN INC 0.02% | 2026-05-12 | 2,341 ( 0.02% ) | 61 358 $ | 2026-05-30 |
David Woodhouse active positions
| Companies | Position | Start |
|---|---|---|
| SURROZEN, INC. | Chairman | 2023-03-31 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Director/Board Member | 2020-09-24 |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Chief Executive Officer | 2025-09-08 |
Former positions of David Woodhouse
| Companies | Position | End |
|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2014-12-31 |
| AMGEN INC. | Corporate Officer/Principal | - |
| NGM BIOPHARMACEUTICALS, INC. | Chief Executive Officer | - |
Training of David Woodhouse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- David Woodhouse
Choose MarketScreener 
